Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease

Aims: The pathophysiological role of iron in Parkinson's disease (PD) was assessed by a chelation strategy aimed at reducing oxidative damage associated with regional iron deposition without affecting circulating metals. Translational cell and animal models provided concept proofs and a delayed...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Devos, David, Moreau, Caroline, Devedjian, Jean Christophe, Kluza, Jérome, Petrault, Maud, Laloux, Charlotte, Jonneaux, Aurélie, Ryckewaert, Gilles, Garçon, Guillaume, Rouaix, Nathalie, Duhamel, Alain, Jissendi, Patrice, Dujardin, Kathy, Auger, Florent, Ravasi, Laura, Hopes, Lucie, Grolez, Guillaume, Firdaus, Wance, Sablonnière, Bernard, Strubi-Vuillaume, Isabelle, Zahr, Noel, Destée, Alain, Corvol, Jean-Christophe, Pöltl, Dominik, Leist, Marcel, Rose, Christian, Defebvre, Luc, Marchetti, Philippe, Cabantchik, Z. Ioav, Bordet, Régis
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Mary Ann Liebert, Inc. 2014
Gaiak:
Original Research Communication
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4060813/
https://ncbi.nlm.nih.gov/pubmed/24251381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/ars.2013.5593
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak